May 23, 2012

Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

MR imaging findings are a stronger predictor of pathologic response to NACT than clinical assessment, with the greatest advantage observed with the use of volumetric measurement of tumor response early in treatment.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Hylton et al. (Wed,) studied this question.

synapsesocial.com/papers/69de98ee5e582bd3c5e93bf9 https://doi.org/https://doi.org/10.1148/radiol.12110748

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound2004 · 172 citations
2MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 68832005 · 165 citations
3I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy2009 · 770 citations
4Regression Modeling Strategies2001 · 9,281 citations
5Utility of Magnetic Resonance Imaging in the Management of Breast Cancer: Evidence for Improved Preoperative Staging1999 · 382 citations

Preguntar a la IA

Me gusta

Guardar